课题基金 / 基金详情

Growth arrest signal in esophageal cancer. Biological significance and clinical implication of EGF-STAT signal transduction system.

Growth arrest signal in esophageal cancer. Biological significance and clinical implication of EGF-STAT signal transduction system.
食管癌的生长停滞信号。
批准号:
10470241
负责人:
SHIMADA Yutaka
金额:
$7.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SHIMADA Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
EGF-STAT信号通路在正常食管鳞状细胞(NESC)和食管鳞癌(SCC)中均有表达,在本实验室已建立的三种食管鳞癌细胞系中,EGF-STAT信号通路均有表达。在这些细胞系中,EGF刺激对活细胞的生长抑制作用显着增加。我们通过Caspase和Bc1-2/Bax家族的级联反应证实了细胞凋亡的证据。另一方面,在NESC中,用原代培养的方法证实了EGF刺激STAT1和STAT3的激活,但没有明显的细胞死亡的证据。我们认识到,即使在信号转导相同的情况下,正常细胞和癌细胞的表型也存在显著差异。此外,免疫细胞化学显示EGF刺激的NESC中STAT1和STAT3在细胞核内聚集,并在体内显示它们对蛋白质的激活。我们认为EGF-STAT信号通路在NESC和SCC中发挥了作用,未来还需要对正常细胞的生物学意义进行进一步的评估。在我们的实验结果假设的治疗模型中,证实了干扰素γ通过凋亡抑制细胞生长的作用。EGF-STAT信号通路在许多SCC细胞系中均有缺失,提示EGF-STAT信号通路可能具有肿瘤抑制作用。还需要进一步研究其他致病因素以及这些因素的生物学意义。通过这项研究,我们的研究可能会对食道癌的治疗有所帮助。
英文摘要
EGF-STAT signaling pathway was maintained in both the normal esophageal squamous cell (NESC) and the esophageal squamous cell carcinoma (SCC).In three esophageal SCC cell lines which had been established in our laboratory, EGF-STAT signaling pathway was maintained. In these cell lines a remarkable increase in growth inhibition of viable cells with EGF-stimulation was demonstrated. We were able to show that the evidence of Apoptosis through the cascade of Caspase and Bc1-2/Bax family.In NESC, on the other hand, activation of STAT1 and STAT3 by EGF-stimulation was confirmed using the primary culture method, but obvious evidence of cell death was not demonstrated. We recognized difference in remarkable phenotype between normal cell and cancer cell even when signaling transduction was the same. Furthermore nucleus accumulation of STAT1 and STAT3 by EGF-stimulation in NESC was demonstrated using immunocytochemistry and their activation of protein were showed in vivo. We are suggesting that EGF-STAT signaling pathway played a role in NESC and SCC.A further examination of biological significance in normal cell is needed to be evaluated in the future.In the treatment model supposed from our experiment results, the effect of cell growth inhibition through Apoptosis by interferon gamma was demonstrated. It is suggested that EGF-STAT signaling pathway plays the role of tumor suppressor because the loss of this signaling pathway is recognized in many SCC cell lines.We summarized that EGF-STAT signaling pathway acts as a growth inhibitor. Further investigation of other contributing factors and the biological significance of these factors is needed. With this research our investigation may be useful for the treatment of esophageal cancer.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Harada H: "Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma"Cancer Res. 59. 3724-3729 (1999)
Harada H:“淋巴结转移与食管鳞状细胞癌染色体 13q12-13 上的等位基因丢失有关”Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uchida S: "In oesophageal squamous cell carcinoma vascular endothelial growth is associated with p53 mutation advanced stage and poor prognosis"Br J Cancer. 77. 1704-1709 (1998)
Uchida S:“在食管鳞状细胞癌中,血管内皮生长与 p53 突变晚期和不良预后相关”Br J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimada Y.: "Prognostic factors of oesophageal squamous cell carcinoma from the perspective ot molecular biology"Br J Cancer. 80. 1281-1288 (1999)
Shimada Y.:“从分子生物学角度探讨食管鳞状细胞癌的预后因素”Br J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uchida S: "Motility related protein(MRP1/CD9)and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma"Br J Cancer. 79. 1168-1173 (1999)
Uchida S:“运动相关蛋白 (MRP1/CD9) 和 KAI1/CD82 表达与食管鳞状细胞癌的淋巴结转移呈负相关”Br J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Research on the treatment of esophageal cancer with anti-human fibroblast growth factor receptor like-1
    • 批准号:
      26293302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.4万
    • 财政年份:
      2014
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    Detection of gastrointestinal cancer biomarkers by next-generation mass spectrometry and comprehensive gene expression analysis
    Protective effect of Kampo medicine on vascular endothelial functionin patients with metabolic syndrome
    • 批准号:
      22590649
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2010
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    Research for the establishment of pluripotent stem cells from normal human culture cells and tissue engineering
    • 批准号:
      22659228
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.04万
    • 财政年份:
      2010
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    国内基金
    海外基金
    基于巨噬细胞-STAT3-Exo 探讨积雪草防治 SLE的机制研究
    • 批准号:
      ZCLQN26H2901
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      季巾君
    • 依托单位:
    瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
    • 批准号:
      JCZRLH202600778
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    STAT3/C/EBPD-SLC5A12生物轴调控内质网应激相关蛋白乳酸化修饰在脓毒症急性肺损伤中的作用及机制研究
    • 批准号:
      JCZRLH202602096
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    利妥昔单抗经B细胞耗竭调控SOST/STAT3磷酸化抑制成纤维细胞活化治疗系统性硬化症相关间质性肺疾病(SSc-ILD)的作用机制研究
    • 批准号:
      2026JJ80940
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黄婧
    • 依托单位: